Skip to content

Clinical Trial on Acupuncture Treatment for Mild to Moderate Parkinson's Disease

Clinical Trial on Acupuncture Treatment for Mild to Moderate Parkinson's Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002031
Enrollment
Unknown
Registered
2025-10-28
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

control group:Treatment solely involves oral administration of conventional medications for Parkinson's disease. Specific drugs include, but are not limited to: levodopa/carbidopa, dopamine receptor a
trial group:The trial group received electroacupuncture treatment twice a week for a total of 12 weeks, in addition to the treatment provided to the control group.

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the Western medicine and traditional Chinese medicine diagnostic criteria established with reference to the "Chinese Diagnostic Criteria for Parkinson's Disease (2016 Edition)", "Diagnostic and Efficacy Evaluation Criteria for Senile Tremor Syndrome in Traditional Chinese Medicine (Trial)", and "Expert Consensus on Clinical Diagnosis and Treatment of Parkinson's Disease (Tremor-Predominant Pattern) in Traditional Chinese Medicine"; (2) Classified as mild or moderate on the modified Hoehn-Yahr scale; (3) Aged between 50 and 80 years, regardless of gender; (4) Voluntary participation in this study, acceptance of relevant examinations and treatments, and signing of the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals with various forms of parkinsonian syndromes; (2) Poor compliance and inability to cooperate with treatment (including failure to adhere to prescribed medication and acupuncture, or a history of needle fainting that may affect treatment efficacy due to intolerance to acupuncture); (3) Those who have received other relevant treatments that may interfere with the outcomes of this study; (4) Individuals with severe cardiovascular, hepatic, renal, or hematopoietic system diseases, malignancies, mental disorders, or those unable to communicate effectively; (5) Pregnant or lactating patients; (6) Patients with skin diseases, limb deformities, or other conditions in the acupoint areas selected for this study that preclude the administration of acupuncture treatment.

Design outcomes

Secondary

MeasureTime frame
Trail Making Test A and B;Hoehn-Yahr Staging Scale;Traditional Chinese Medicine Quality of Life Scale for Parkinson's Disease;Mini-mental State Examination;Weekly bowel movement frequency;Time and number of steps taken to walk 20 meters;Hamilton depression scale;

Primary

MeasureTime frame
UPDRS I II III;

Countries

China

Contacts

Public ContactHuashunCui

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

huashunchoi@126.com15796727271

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026